RaySearch Establishes Sales and Support Company in Germany

RaySearch has established a German subsidiary, RaySearch Germany GmbH. The new subsidiary is fully responsible for the marketing, sales and service of RaySearch’s proprietary treatment planning system RayStation® in Germany, Austria and the German-speaking parts of Switzerland. It will serve new as well as existing customers such as DKFZ and WPE in Germany and MedAustron in Austria.

The German subsidiary is led by Mr. Radu Pintea. Mr. Pintea is a trained medical physicist and brings over 20 years' experience from the radiation therapy industry and has held senior sales positions primarily in treatment planning but also in medical equipment and accessories for radiotherapy.

"I am very happy to join RaySearch in this exciting phase. RayStation® is clearly the leading treatment planning system on the market with unique features such as multi-criteria optimization and full support for adaptive therapy and proton therapy. I am off to a flying start and look forward to working with new and existing customers in the region. We will participate as an exhibitor at all the important trade shows in 2014 starting with DEGRO in Düsseldorf," says Radu Pintea, Business Director of RaySearch Germany GmbH.

Johan Löf, CEO of RaySearch, comments: "We have been active in Germany for almost five years since WPE in Essen became the very first RayStation® customer in 2009. Over the years we have supported the German-speaking market from Stockholm. As we now see an increasing demand from the region it is time to increase our presence and I am very happy to welcome Radu Pintea to RaySearch. With his extensive experience he will be instrumental to expand and support our growing customer base in the region."

About RayStation®
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at 2,500 clinics in more than 65 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...